Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Uveal Melanoma 2Macular Edema 2von Hippel-Lindau Disease 1Retinal Diseases 1Neoplasms 1Melanoma 1Glaucoma, Neovascular 1Conjunctival Neoplasms 1

Interventions

Ranibizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Macular Edema × Ranibizumab × Clear all
NCT00089765 2017-07-02

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
5 enrolled

von Hippel-Lindau Disease, Macular Edema, Neoplasms

NCT00765921 2016-12-02

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Massachusetts Eye and Ear Infirmary

Phase 1 Completed
40 enrolled
Dermatologic

Uveal Melanoma, Macular Edema, Glaucoma, Neovascular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡